HealthTimes

Donald Trump speaking at a podium, representing US government leadership on international health agreements
Africa HIV/AIDS

Leaked Memo Shows U.S. May Cut HIV Aid to Zambia to Secure Mineral Access

Michael Gwarisa

Michael Gwarisa A report in The New York Times reveals that the U.S. State Department is considering a significant reduction in health assistance to Zambia as a negotiating tool to gain greater access to the country’s critical minerals. According to The New York Times, a draft memo prepared for Secretary of State Marco Rubio suggests

Read More
Dr Douglass Mombeshora, Zimbabwe’s Minister of Health and Child Care, cutting the ribbon to officially launch Lenacapavir, a long-acting injectable HIV prevention drug.
Africa Health News HIV/AIDS

Rare HIV ‘Breakthrough’ Cases Reported in Lenacapavir PrEP Trials Across Africa

Michael Gwarisa

Michael Gwarisa As more African countries begin to introduce lenacapavir into their HIV prevention programmes, scientists are examining new data showing that a small number of people became infected with HIV while using the medication. The drug’s rollout now extends beyond just one or two nations. Countries that have started distributing the twice-yearly injectable or

Read More
Black hand holding a lenacapavir injection and medicine vial symbolising HIV prevention and South Africa’s plan to locally manufacture the long-acting HIV drug.
Africa Health News HIV/AIDS

South Africa Urged to Secure Better Lenacapavir License Terms With Gilead Before Local Manufacturing

Michael Gwarisa

Michael Gwarisa Doctors Without Borders (MSF) has urged South Africa not to rush into local manufacturing of lenacapavir, an injectable HIV prevention drug, without first negotiating stronger, more equitable license terms or using a compulsory license to bypass patent restrictions. Their call follows a recent announcement by the South African government that it is negotiating

Read More
US Ambassador Pamela Tremont speaks on the wind-down of American health assistance in Zimbabwe.
Breaking News Health News HIV/AIDS

Zimbabwe–US Health Deal Collapses, Triggering Wind-Down of US$367m Aid and Raising Fears for HIV Response

healthTimesco

Kuda Pembere & Michael Gwarisa Zimbabwe’s health sector faces renewed uncertainty after the collapse of a proposed US$367 million health assistance agreement with the United States, prompting Washington to begin winding down major health interventions in the country. The development follows a directive by President Emmerson Mnangagwa instructing the Ministry of Foreign Affairs and International

Read More
Illustration of HIV infection showing virus attacking immune cells, with arrows indicating disease progression.
HIV/AIDS Features

Where Zimbabwe Stands in the Fight Against HIV

Michael Gwarisa

Michael Gwarisa In 1985, Zimbabwe recorded its first confirmed case of HIV, marking the start of a national epidemic. By the mid-1980s, cases were rising rapidly, particularly in Hurungwe District, where formal surveillance began in 1986. By the end of the decade, nearly 10 percent of Zimbabwe’s adult population had already been infected. Nearly four

Read More
Black hand holding a lenacapavir injection and medicine vial symbolising HIV prevention and South Africa’s plan to locally manufacture the long-acting HIV drug.
Breaking News HIV/AIDS

Zimbabwe’s Lenacapavir Rollout Date Finally Announced

healthTimesco

Michael Gwarisa Following weeks of anticipation, the Zimbabwean government has finally announced the dates for the rollout of lenacapavir, an injectable pre-exposure prophylaxis drug. The rollout had initially been scheduled for January 2026. According to The Herald, the Permanent Secretary in the Ministry of Health and Child Care, Dr Aspect Maunganidze, confirmed that the drug

Read More
Black hand holding a lenacapavir injection and medicine vial symbolising HIV prevention and South Africa’s plan to locally manufacture the long-acting HIV drug.
Features HIV/AIDS

Who Should Not Take Lenacapavir? Key Health Conditions to Consider Before the Rollout

Michael Gwarisa

By Michael Gwarisa As Zimbabwe prepares to roll out Lenacapavir, an injectable pre-exposure prophylaxis drug, anticipation is growing among people waiting for their turn. The initial consignment consists of just 2,000 doses, meaning distribution will focus on groups classified as high risk. Despite its high efficacy, Dr Owen Mugurungi, Director of AIDS, TB and Malaria

Read More
Black hand holding a lenacapavir injection and medicine vial symbolising HIV prevention and South Africa’s plan to locally manufacture the long-acting HIV drug.
Features HIV/AIDS

Lenacapavir Doses Now In Zimbabwe, But Experts Urge Caution

Michael Gwarisa

Michael Gwarisa As Zimbabwe takes delivery of its first doses of Lenacapavir, the new long-acting injectable for HIV prevention, public health experts are urging citizens to understand that this is not a replacement for existing prevention methods, but rather a powerful addition to the country’s combination prevention approach. The announcement came during a Continuing Medical

Read More
3e55d6a5 dc04 43c6 9808 5f380c79780f 1
Africa Breaking News HIV/AIDS

You Could Get HIV from the Barber Shop, Study Finds

healthTimesco

Michael Gwarisa A South African study has concluded that a person could be exposed to blood borne infections during a haircut or shave at a public barber shop, raising renewed concerns about hygiene standards in informal grooming spaces. The study, published in the South African Medical Journal, found that 42 percent of barber clippers were

Read More
scientists progress cure hiv mrna
Breaking News Global Health HIV/AIDS

Scientists Make Breakthrough Toward Full Cure for HIV

healthTimesco

Researchers say they’ve taken a major step toward finding a cure for HIV. As The Guardian reports, scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne found a way to make the HIV virus visible, potentially laying the groundwork for ways to banish it from the body altogether. As detailed in a paper published

Read More